Stocks and Investing Stocks and Investing
Fri, September 6, 2024

Chris Schott Upgraded (AMRX) to Hold and Held Target at $9 on, Sep 6th, 2024


Published on 2024-10-28 14:07:05 - WOPRAI, Chris Schott
  Print publication without navigation


Chris Schott of JP Morgan, Upgraded "Amneal Pharmaceuticals, Inc." (AMRX) to Hold and Held Target at $9 on, Sep 6th, 2024.

Chris has made no other calls on AMRX in the last 4 months.



There are 3 other peers that have a rating on AMRX. Out of the 3 peers that are also analyzing AMRX, 0 agree with Chris's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Chris


  • Balaji Prasad of "Barclays" Maintained at Buy with Increased Target to $10 on, Tuesday, August 13th, 2024
  • Les Sulewski of "Truist Securities" Maintained at Strong Buy with Increased Target to $10 on, Monday, August 12th, 2024
  • Nathan Rich of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $8 on, Monday, May 6th, 2024
Contributing Sources